CrushSCI.com
Journal Selection & Manuscript Polishing Services
Cell Reports Medicine journal cover Medicine
Back to journal directory

Review Cycle Records

Cell Reports Medicine

Elsevier SCIE OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
266.2Average days
269.5Median days
160Fastest days
411Longest days
4502025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

273 days

Synthetically engineered probiotic suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling

AuthorsYujie Sun; Yu Zhao; Kang Han; Wulong Hu; Guofan Peng; Shengen Yi; Jun Zhou; Jin Hai Zheng

AffiliationsSchool of Biomedical Sciences, Hunan University, Changsha 410082, China; Hunan Key Laboratory of Animal Models and Molecular Medicine, Hunan University, Changsha 410082, Hunan, China; Department of General Surgery, the Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China; Xiangtan Central Hospital, the Affiliated Hospital of Hunan University, Xiangtan 411100, Hunan, China

Source PDF DOI Publisher page
160 days

Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2−breast cancer: A randomized, phase 2 trial FASCINATE-N

AuthorsJun-Jie Li; Lin-Xiaoxi Ma; Peng Ji; Li Chen; Jiong Wu; Guang-Yu Liu; Yi-Feng Hou; Gen-Hong Di; Zhen Hu; Yi-Zhou Jiang; Lei Fan; Zhong-Hua Wang; Ke-Da Yu; Zhi-Ming Shao

AffiliationsDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Key Laboratory of Breast Cancer in Shanghai, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China

Source PDF DOI Publisher page
323 days

Corpora amylacea profiling reveals disease stage and brain region-specific alterations in glycogen metabolism in Alzheimer’s disease patient brains

AuthorsJonathan A.B. Villareal; Tim Bathe; Ana de la Rosa; Rohan V. Sharma; Elvin O. Hernández Gómez; Alison M. Ryan; Tara R. Hawkinson; Anthony M. Tuzzolo; Eduardo Medina-Parrilla; Jennifer L. Phillips; Wangchen Tsering; Andrea A. Iturbe; Benoit I. Giasson; Ramon C. Sun; Matthew S. Gentry; Stefan Prokop

AffiliationsDepartment of Pathology, Immunology & Laboratory Medicine, University of Florida, Gainesville, FL 32610, USA; Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA; Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA; Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL 32608, USA; McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA; Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL 32610, USA; Center for Advanced Spatial Biomolecule Research, University of Florida, Gainesville, FL, USA; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, 81377 Munich, Germany; Graduate School of Systemic Neurosciences (GSN), Department Biology II Neurobiology, LMU Munich, 82152 Planegg-Martinsried, Germany

Source PDF DOI Publisher page
213 days

DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases

AuthorsTeodor G. Calina; Elena Grafenhorst; Simon Schallenberg; Markus Möbs; Bjarne Daenekas; Alexandru A. Sabo; BaoQing Chen; Ines Koch; Tobias Janik; Michael Churchman; Charlie Gourley; Elizabeth L. Christie; Catalin Vasilescu; Vlad Herlea; Wolfgang D. Schmitt; Nicolae Leopold; Florian Heitz; Angelina Vlaski; Yuri Tolkach; Felix Bremmer; Frederick Klauschen; Reinhard Büttner; Philipp Ströbel; Eike Burandt; Guido Sauter; Frank L. Heppner; Eliane T. Taube; Jalid Sehouli; Ioana E. Braicu; Philipp Euskirchen; David Horst; Kylie L. Gorringe; David Capper; Mihnea P. Dragomir

AffiliationsFaculty of Physics, Babeş-Bolyai University, Cluj-Napoca, Romania; TGC Ventures UG, Berlin, Germany; Institute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; Department of Pediatric Cardiology, Pulmonology and Pediatric Intensive Care Medicine, University Children’s Hospital Tübingen, Tübingen, Germany; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China; Nicola Murray Centre for Ovarian Cancer Research, CRUK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, Scotland, UK; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania; Department of Pathology, Fundeni Clinical Institute, Bucharest, Romania; Department of Gynecology and Gynecologic Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany; Institute of Pathology, Ludwig-Maximilians-Universität Munich, Munich, Germany; Institute of Pathology, University Hospital Cologne, Köln, Germany; Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany; Department of Gynaecology, European Competence Center for Ovarian Cancer, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; North Eastern German Society for Gynecological Cancer, Tumor Bank Ovarian Cancer Network, Berlin, Germany; Berlin Institute of Health, Berlin, Germany

Source PDF DOI Publisher page
353 days

Combination of exosome vaccines, lenvatinib, and anti-PD-1 eradicates tumor in autochthonous hepatocellular carcinoma mice

AuthorsBingfeng Zuo; Xuening Liu; Zheng Zhang; Zhenqiang Xu; Yanzhi Zhong; Yang Zhang; Qian Yang; Zezhen Yu; Kangjie Zhao; Yali Zhang; Yiqi Seow; HaiFang Yin

AffiliationsState Key Laboratory of Experimental Hematology & the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics & Division of Medical Technology & School of Basic Medical Sciences, Tianjin Medical University, Qixiangtai Road, Heping District, Tianjin 300070, China; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, China; Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (ASTAR), 60 Biopolis Street, Genome, Singapore 138672, Republic of Singapore

Source PDF DOI Publisher page
227 days

Nilotinib induces immunogenic cuproptosis to potentiate cancer immunotherapy

AuthorsLei Yao; Deze Zhao; Yu Meng; Yihuang Liu; Hui Su; Danyao Chen; Ziyu Guo; Daishi Li; Linfeng Li; Qian Zhou; Shengchao Xu; Furong Zeng; Xiang Chen; Ledu Zhou; Guangtong Deng

AffiliationsDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China; Department of Hepatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha 410008, China; Hunan Engineering Research Center of Skin Health and Disease, Central South University, Changsha 410008, China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Central South University, Changsha 410008, China; National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China; Hu Nan Key Laboratory of Aging Biology, Changsha 410008, China; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China; Department of Neurosurgery, Xiangya Hospital, Central South University, No.87, Xiangya Road, Changsha, Hunan 410008, China

Source PDF DOI Publisher page
411 days

A poly(I:C)/QS-21-based in situ vaccine synergizes with anti-PD-1 therapy to overcome tumor immunoresistance

AuthorsWenbo Zhang; Xinrui Ni; Luoyi Zhuo; Jiangrui Liu; Guang Yang; Jianming Li; Lingai Tang; Xiuli Du; Chun Shan; Guoqiang Feng; Wenguang Wang; Qi Gao; Qiang Sui; Min Xia; Chunwang Yuan; Dexiang Chen; Yong Yang; Duowei Wang; Xianjing Li

AffiliationsSchool of Translational Research, China Pharmaceutical University, Nanjing 211198, China; Shanghai Anyikang Biotechnology Co., LTD, Shanghai 200131, China; Maxvax Biotechnology Co., LTD, Chengdu 610200, China; Center of Interventional Oncology and Liver Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China; Interventional Department of Liver Diseases and Tumors with Integrated Traditional Chinese and Western Medicine, The Second Hospital of Hohhot, Hohhot 010020, China; School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China; Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing 211198, China

Source PDF DOI Publisher page
163 days

Discovery of a peripherally restricted α2AAR agonist as a safe and broad-spectrum oral analgesic

AuthorsZhiqiang Cheng; Cedric Moore; Haijiao Li; Yang Xu; Larry Zhu

AffiliationsAglaeaPharma INC., Camden, DE 19934, USA; AlpheraBio LLC, Boston, MA 02108, USA

Source PDF DOI Publisher page
269 days

Spinal cord stimulation modulates post-synaptic inhibition to improve arm neuromotor control after chronic stroke

AuthorsLuigi Borda; Nikhil Verma; Erynn Sorensen; Erick Carranza; Roberto de Freitas; Scott Ensel; Amy Boos; Peter C. Gerszten; Daryl P. Fields; George F. Wittenberg; Lee E. Fisher; Elvira Pirondini; Marco Capogrosso; Douglas J. Weber

AffiliationsNeuroMechatronics Lab, Carnegie Mellon University, Pittsburgh, PA, USA; Department of Mechanical Engineering, Carnegie Mellon University, Pittsburgh, PA, USA; The Neuroscience Institute, Carnegie Mellon University, Pittsburgh, PA, USA; Rehabilitation and Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA; Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA; Clinical and Translational Science Institute (CTSI), University of Pittsburgh, Pittsburgh, PA, USA; Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, USA; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA; TECH-GRECC & HERL, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, USA

Source PDF DOI Publisher page
270 days

Programmable-bacteria-macrophage backpacks for enhanced solid tumor therapy via mechanobiological interplay

AuthorsZhe Fan; Pengfei Chen; Shuangmei Zuo; Kehan Cai; Sitian Li; Haoyang Qin; Rui Li; Kyubae Lee; Tao Chen; Chenwang Jin; Jingchao Li; Yazhou Chen

AffiliationsHenan Institute of Advanced Technology, Zhengzhou University, Zhengzhou 450003, P.R. China; The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, P.R. China; State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, P.R. China; Department of Biomedical Materials, Konyang University, Daejeon 35365, Republic of Korea; Department of Radiology, the First Affiliated Hospital of Xi’an Jiaotong University, 277 West Yanta Road, Xi’an, Shaanxi 710061, P.R. China

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.